Published Date
19/05/2020
Author
Laura Burge
Category
Care & Support
NICE, NHS England and NHS Improvement have taken advice from clinical experts and consulted with patient advisory groups Muscular Dystrophy UK, Treat SMA, and SMA UK to produce two new question-and-answer documents relating to the SMA treatment Spinraza.
The first document, which answers questions relating to access for children, can be accessed here.
- You can find out more about Spinraza here. If you have any questions about access to the treatment, speak to your clinician.